Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)
NCT04377672
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
SARS-CoV-2 Infection
Interventions
BIOLOGICAL:
Anti-SARS-CoV-2 Human Convalescent Plasma
Sponsor
Johns Hopkins University